A detailed history of Frank, Rimerman Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Frank, Rimerman Advisors LLC holds 97,874 shares of PFE stock, worth $2.69 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
97,874
Previous 101,887 3.94%
Holding current value
$2.69 Million
Previous $2.85 Million 0.63%
% of portfolio
0.2%
Previous 0.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$27.7 - $31.39 $111,160 - $125,968
-4,013 Reduced 3.94%
97,874 $2.83 Million
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $2.57 Million - $3.01 Million
101,573 Added 32348.09%
101,887 $2.85 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $8,204 - $10,657
314 New
314 $9.04 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Frank, Rimerman Advisors LLC Portfolio

Follow Frank, Rimerman Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frank, Rimerman Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frank, Rimerman Advisors LLC with notifications on news.